Provider review
Freya Meds review
Its "450,000+ enrolled" claim repeats six times on the homepage alone
Semaglutide is $250 a month quarterly or $297 monthly; tirzepatide $333 and $390. The cheaper annual rates still shown — $150 and $249 — are closed to new customers, per its own refund policy, so budget from the quarterly figure.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Freya Meds corrects several gaps our last check had flagged: named physicians, a LegitScript seal, and full 50-state coverage. Its bundled extras (unlimited consults, group calls, a dietitian) are real differentiators. Its "450,000+ patients" claim, repeated six times on the homepage, is worth noting as a marketing figure we couldn't independently audit — and new customers should budget off the quarterly rate, since the cheaper annual tier is now closed to new subscribers.
Freya Meds is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want bundled extras — unlimited consults, monthly group calls, and a dietitian consultation — included in the price
- You want named, credentialed physicians rather than an anonymous provider pool
- You want full 50-state coverage
Look elsewhere if
- You're budgeting off the $150/$249 legacy annual price — that tier is closed to new subscribers
- You want to cancel with less than 48 hours' notice before your renewal date — once processed, it can't be stopped
- You want a single named compounding pharmacy rather than a described network
What it actually costs
What they advertise
Compounded semaglutide: $250/mo on a quarterly plan — the cheapest tier open to new customers.
What you actually pay, month to month
Monthly (no prepay) runs $297/mo; tirzepatide runs $333/mo quarterly or $390/mo monthly.
The commitment trap
The lowest advertised figure ($150/mo) is a legacy annual rate no longer available to new subscribers — new customers' cheapest option is $250/mo quarterly.
Checked live on Freya Meds's own site at https://freyameds.com/pricing/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Freya Meds bundles in, and what it does not.
Clinician consult
Unlimited doctor consultations.
Bloodwork / labs
Not published.
Follow-ups and dose changes
Monthly group calls.
Human support
One-on-one dietitian consultation.
Injection supplies
Included in the price.
Shipping
No terms published.
Pharmacy, labs and oversight
The pharmacy
Described only as the "Freya Meds Pharmacy Network"; no single facility named.
Oversight
Monthly group calls.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
"450,000+ patients across 50 U.S. states,".
The honest cons
The part they would rather you skipped
Freya Meds' homepage repeats a "450,000+ patients" figure six separate times, a scale claim we could not independently audit against any outside source — worth treating as a marketing figure rather than an confirmed number.
- "450,000+ patients" claim repeated six times on the homepage couldn't be independently audited
- Cheapest legacy annual tier ($150/mo) is closed to new subscribers
- Cancellation requires 48 hours' notice; once a renewal processes, it can't be stopped
- No single named compounding pharmacy, only a described network
None of this is unique to Freya Meds — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Freya Meds is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Freya Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Freya Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.